Publication | Closed Access

Use of a Methyl Hydrazine Derivative (Natulan®), Especially in Hodgkin's Disease

Methyl Hydrazine DerivativePharmaceutical ScienceMedicinePathologyExperimental TherapeuticPharmacotherapyPharmacologyDrug Discovery